You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 13, April 7, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Complementary and Alternative Medicine
 •Cardiovascular System
 •Arrhythmias
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cardiovascular Effects of Ephedra—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: In response to Dr Krantz, we have previously reported that individuals with structural heart disease have baseline QTc intervals elevated to 413 milliseconds if they have left ventricular hypertrophy, 423 milliseconds if they have had a recent myocardial infarction, 438 milliseconds if they have dilated cardiomyopathy, and up to 460 milliseconds during an acute myocardial infarction. Thus, we agree with Krantz that these patients would be at enhanced risk of exceeding 500 milliseconds with the degree of QTc interval increase we had shown in our healthy sample.1-2

Dr Ness points out that these dietary weight loss products contain multiple ingredients, several of which may alter blood pressure. It is disturbing that the amount of goldenseal and Siberian ginseng in the product cannot be known. I also agree with Ness that just because ephedra is now banned by the Food and Drug Administration, this does not mean that a . . . [Full Text of this Article]

C. Michael White, PharmD
cmwhite{at}harthosp.org
University of Connecticut School of Pharmacy
Storrs



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Cardiovascular Effects of Ephedra

JAMA. ;291():1560-1560.
FULL TEXT  

Cardiovascular Effects of Ephedra

JAMA. ;291():1560-1560.
FULL TEXT  

Electrocardiographic and Hemodynamic Effects of a Multicomponent Dietary Supplement Containing Ephedra and Caffeine: A Randomized Controlled Trial
, , , , , and
JAMA. ;291():216-221.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.